Skip to main content
. 2018 Oct 12;31(5):411–418.

Table 2.

Patients’ antibiotic treatments for recurrent Clostridium difficile infection episodes previous to fecal microbiota transfer

Patient number 1st R-CDI treatment 2nd R-CDI treatment 3rd R-CDI treatment 4th R-CDI treatment 5th R-CDI treatment 6th R-CDI treatment 7th R-CDI treatment
1 Vancomycin Vancomycin taper Vancomycin taper Fidaxomicin Vancomycin taper Metronidazole Vancomycin taper
2 Vancomycin taper Fidaxomicin Vancomycin
3 Vancomycin taper Vancomycin taper Fidaxomicin Vancomycin
4 Metronidazole Vancomycin Fidaxomicin, vancomycin taper
5 Vancomycin, vancomycin taper Combined metronidazole and Vancomycin, Vancomycin taper Fidaxomicin Fidaxomicin, Tapered vancomycin
6 Vancomycin taper Metronidazole, vancomycin taper Fidaxomicin
7 Fidaxomicin Vancomycin taper
8 Vancomycin taper Fidaxomicin Vancomycin taper Vancomycin taper
9 Vancomycin taper Fidaxomicin
10 Vancomycin Fidaxomicin Metronidazole
11 Fidaxomicin Vancomycin taper
12 Vancomycin Fidaxomicin Vancomycin taper
13 Fidaxomicin Vancomycin taper

R-CDI. Recurrent Clostridium difficile infection. Metronidazole: Metronidazole 500mg/8 hours 10 days; Vancomycin: Vancomycin 125mg/6 hours 10days; Vancomycin taper: Vancomycin in tapered regimen for a minimum of 6-8 weeks; Fidaxomicin: Fidaxomicin 200mg/12hours 10 days